This activity has been rescheduled from October 29, 2009. We are sorry for the inconvenience and hope you can join us in December.
Major depressive disorder (MDD), schizophrenia, bipolar disorder and other psychiatric disorders have been listed by the World Health Organization as being some of the major causes of illness and disability in the world. By the year 2020, the WHO has projected that MDD, bipolar disorder and schizophrenia will be among the top 10 causes of morbidity in the world and will be the second leading cause of illness and disability (Murray and Lopez 1997).
Recent advances in clinical trials have led to a change in the way we view current psychiatric medications. There is a pressing need for these findings to be communicated to psychiatric clinicians and translated in a meaningful way to improve the outcomes of patients suffering from psychiatric disorders. This CME activity will provide this needed education to a broad audience of practitioners who see patients with MDD, bipolar disorder and other psychiatric disorders in daily practice.
Learning Objectives
Participants who attend this conference will be able to:
-
Describe state of the art data on the role of current psychotropic medications in the treatment of major psychiatric disorders like schizophrenia, MDD, bipolar disorder, anxiety disorders etc
-
Apply rationale prescribing practices in keeping with recent guidelines released by the American Psychiatric Association.
-
Identify future developments in psychopharmacology which may impact practice.
-
State the role of various psychopharmacological and psychosocial treatment in challenging situations.
Thursday, December 3, 2009
7 AMA PRA Category 1 CreditsTM
Omni New Haven Hotel at Yale
155 Temple Street
New Haven, CT
Registration Fees
Registration fee includes all conference materials, continental breakfast, refreshment breaks and lunch.
Physicians - $125
Psychiatrists - $125
NPs/PAs- $125
Non-Yale Residents/Fellows* - $50
Yale Residents/Fellows* - Complementary
*A letter of verification from department head must accompany registration. If registering online, letter should be sent separately to Yale CME address below.
All cancellations must be received in writing (or via email) at least one week prior to the start of the conference to receive a refund. Any requests for refunds received after this date, or by telephone, will not be honored.
Center for Continuing Medical Education
P.O. Box 7619
New Haven, CT
06519
Accreditation Statement
The Yale School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.
The American Medical Association has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credit.
Designation Statement
The Yale School of Medicine designates this educational activity for a maximum of 7 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Policy
It is the policy of Yale School of Medicine, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating as speakers in these programs are required to disclose any relevant financial relationship(s) they (or spouse or partner) have with a commercial interest that benefits the individual in any financial amount that has occurred within the past 12 months; and the opportunity to affect the content of CME about the products or services of the commercial interests. The Center for Continuing Medical Education will ensure that any conflicts of interest are resolved before the educational activity occurs.
.
